Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation (Indonesia University)
- Development stage
- Unknown
- Lead developer
- Universitas Indonesia
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intracoronary
01
Overview
Umbilical cord mesenchymal stem cell (UC-MSC) transplantation is an investigational allogenic cell therapy being developed by Indonesia University (Universitas Indonesia) for the treatment of ST-elevation myocardial infarction (STEMI). The therapy involves the intracoronary administration of approximately 50 million UC-MSCs, typically delivered 10-15 days following a primary percutaneous coronary intervention (PCI). UC-MSCs are multipotent stem cells characterized by their significant immunomodulatory, anti-inflammatory, and pro-angiogenic properties. In the context of acute myocardial infarction, these cells are intended to reduce the size of the myocardial infarct, prevent adverse cardiac remodeling, and improve overall cardiac function. The therapeutic effect is primarily mediated through paracrine signaling, where the transplanted cells secrete various growth factors and cytokines that promote tissue repair, stimulate angiogenesis, and inhibit cardiomyocyte apoptosis.
- Other names
- Allogenic Umbilical Cord Mesenchymal Stem Cell transplantationUC MSCIntracoronary Allogenic Umbilical Cord Mesenchymal Stem Cell transplantation
Beyond the preview
Go deeper on Umbilical cord mesenchymal stem cell transplantation (Indonesia University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Umbilical cord mesenchymal stem cell transplantation (Indonesia University).